ALK-Abelló
ALK | CO
Overview
Corporate Details
- ISIN(s):
- DK0061802139
- LEI:
- 529900SGCREUZCZ7P020
- Country:
- Denmark
- Address:
- Bøge Alle 6-8, 2970 Hørsholm
- Website:
- https://www.alk.net
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
At ALK, we go to work every day to make a difference for the many people with allergy around the world. It is our ambition to make life with allergy surprisingly simple for as many people as possible, and we build upon our strong heritage as a pioneer in allergy immunotherapy, when we continue to innovate, develop and market new products and solutions to help improve the health of people with allergy. Every day, our employees contribute to our aspiration of becoming the world leader in allergy by coming to work to do their best in the pursuit of providing new and better allergy treatments and solutions. We work in a high-energy, international setting where it is imperative that our people thrive and develop. Creativity, influence and opportunities are key elements in developing our people. ALK is a global company with production sites in Denmark, France, Spain and the United States. ALK was founded in Copenhagen in 1923 and today we employ around 2,300 people around the world.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for ALK-Abelló.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-12 14:45 |
Earnings Release
|
Danish | 103.0 KB | |
2025-08-12 14:45 |
Earnings Release
|
Danish | 3.7 KB | |
2025-08-12 14:45 |
Earnings Release
|
English | 108.6 KB | |
2025-08-12 14:45 |
Earnings Release
|
English | 3.2 KB | |
2025-07-18 14:01 |
Regulatory News Service
|
Danish | 174.9 KB | |
2025-07-18 14:01 |
Legal Proceedings Report
|
English | 5.2 KB | |
2025-07-18 14:01 |
Regulatory News Service
|
Danish | 5.3 KB | |
2025-07-18 14:01 |
Regulatory News Service
|
English | 223.5 KB | |
2025-05-02 13:59 |
Regulatory News Service
|
English | 6.2 KB | |
2025-05-02 13:59 |
Regulatory News Service
|
Danish | 6.4 KB | |
2025-05-02 13:59 |
M&A Activity
|
English | 210.1 KB | |
2025-05-02 13:59 |
Earnings Release
|
Danish | 174.8 KB | |
2025-04-23 15:58 |
Regulatory News Service
|
Danish | 162.4 KB | |
2025-04-23 15:58 |
Regulatory News Service
|
English | 131.9 KB | |
2025-04-23 15:58 |
Regulatory News Service
|
Danish | 4.4 KB |
Automate Your Workflow. Get a real-time feed of all ALK-Abelló filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ALK-Abelló via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
POLAREAN IMAGING PLC | United States of America | POLX | |
![]() |
Poltreg S.A. | Poland | PTG | |
![]() |
Poxel | France | POXEL | |
![]() |
PREDILIFE | France | ALPRE | |
![]() |
PROSPEX ENERGY PLC | United Kingdom | PXEN | |
![]() |
Prostatype Genomics AB | Sweden | PROGEN | |
|
Psych Capital Plc | United Kingdom | PSY | |
![]() |
Pure Biologics S.A. | Poland | PUR | |
![]() |
Puretech Health PLC | United States of America | PRTC | |
![]() |
Purple Biotech Ltd. | Israel | PPBT |